Heart Failure
- Obesity Linked to Lower Short-Term Mortality in Patients With HF With Well-Nourished Status
- Omecamtiv Mecarbil Beneficial in Black Patients With HFrEF
- Quadriceps Strength Linked to Lower Risk for Heart Failure After AMI
- Outcomes Following Benzodiazepine Therapy in Patients With Acute Heart Failure
- The Effect of Empagliflozin on Risk for Heart Failure Events After Hospitalization
- Antihyperglycemic Interventions Decrease MACE Risk Dependent on Hemoglobin A1C Levels
- Moderately Accelerated Pacing in Patients With a Pacemaker and HFpEF
- The Relationship Between HF and Bariatric Surgery in Patients With Obesity
- Similar In-Hospital and Post-Discharge Outcomes in Rural vs Urban Heart Failure
- Dapagliflozin for HF and Similar Benefits in Black and White Patients Regardless of LVEF
- Dapagliflozin’s Relationship With NT-proBNP Level Following Anterior STEMI
- Opioids Do Not Effectively Treat Breathlessness in Heart Failure
Clinical Tools
Powered by
Powered by 
